Tag Archives: centers for disease control and prevention

The Centers for Disease Control and Prevention will move to exercise an option under a 2016 contract with Irving, Texas-based health care company McKesson (NYSE: MCK) for the distribution of vaccines and associated supplies intended for pandemic vaccination efforts.

TYSONS CORNER, VA, July 23, 2020 — ICF (Nasdaq: ICFI) will help the Centers for Disease Control and Prevention develop an evaluation and implementation framework for emerging information technology platforms under a five-year, $9M Alliant 2 task order, ExecutiveBiz reported July 15.

Donna Knutson, former deputy director of the Centers for Disease Control and Prevention’s National Center for Environmental Health and the Agency for Toxic Substances and Disease Registry, has joined Guidehouse to provide business strategy advice.

Potomac Officers Club hosted its Supply Chain Resilience and COVID-19 Virtual Event on June 11th, featuring keynote speaker Rear Adm. John Polowczyk, supply chain task force lead for the Federal Emergency Management Agency (FEMA), and an expert panel with federal, academic and industry thought leaders. 

The U.S. intelligence community has initiated changes to its work operations to ensure continuity, meet mission needs and safeguard the health of its workforce amid the coronavirus pandemic, Government Executive reported Thursday.

The Department of Defense’s office of the chief management officer has released a five-phased plan to provide guidance to commanders and supervisors as they prepare military personnel, government civilian employees and contractors to return to normal operations while ensuring their safety amid the COVID-19 pandemic.

Westat reported on Tuesday that it will support clients during the COVID-19 pandemic in a variety of areas, including public health, epidemiologic research and social and economic impact studies to lead to strategies for solutions through contract awards.

The National Institutes of Health has launched a new initiative to accelerate the development and commercialization of testing technologies for the new coronavirus. The Rapid Acceleration of Diagnostics program will use $1.5B in federal stimulus funds to invest in efforts that work on new COVID-19 testing technologies, NIH said Thursday.

The National Institutes of Health and three other U.S. health agencies have teamed up with the Foundation for the NIH, European Medicines Agency and 16 biopharmaceutical companies to speed up the development of vaccines and treatments for COVID-19. The Accelerating COVID-19 Therapeutic Interventions and Vaccines partnership will work to streamline clinical trials, coordinate regulatory processes and use assets to accelerate response to the coronavirus pandemic and other future health emergencies, NIH said Friday.

The White House has asked Congress for $45.8B in additional funding for fiscal year 2020 and authorities to facilitate ongoing coronavirus preparedness and response efforts. Russ Vought, acting director of the Office of Management and Budget, wrote in a Wednesday letter to Congress that the Trump administration wants to amend its FY 2021 requested budget to increase the funding of the Centers for Disease Control and Prevention to $8.3B.